Get started
Author

Annemie Rutten

Observed names: A Rutten, A. Rutten, Rutten, Annemie
Observed institutions: Universitat Autònoma de Barcelona, University of Antwerp, University of Cambridge, Erasmus MC, Hospital Clínico San Carlos, GZA Ziekenhuizen Campus Sint-Augustinus, Antwerp University Hospital, University Medical Center Hamburg-Eppendorf, Hospital Arnau de Vilanova, Vall d'Hebron Hospital Universitari, Iridium Kankernetwerk, University Hospital of Heraklion, Istituti Ospitalieri di Cremona, Vall d'Hebron Institute of Oncology, Ziekenhuis aan de Stroom, GZA Ziekenhuizen, Heinrich Heine University Düsseldorf, Imperial College London, European Institute of Oncology, Institut Curie, Sapienza University of Rome, Saarland University, KU Leuven
ORCID: 0009-0006-7725-4967
Observed ORCID: 0009-0006-7725-4967
OpenAlex ID: A5023382063
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
2014 · François-Clément Bidard, Dieter J Peeters, et al. · The Lancet Oncology · 865
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
2018 · Massimo Cristofanilli, Jean-Yves Pierga, et al. · Critical Reviews in Oncology/Hematology · 282
PDF
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
2024 · Robert J. Motzer, Camillo Porta, et al. · Journal of Clinical Oncology · 222
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
2013 · D J E Peeters, B De Laere, et al. · British Journal of Cancer · 179
PDF
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
2018 · Bram De Laere, Steffi Oeyen, et al. · Clinical Cancer Research · 178
PDF
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
2017 · Daniel P Petrylak, Ronald de Wit, et al. · The Lancet · 175
PDF
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
1990 · R C Coombes, P S Schein, et al. · Journal of Clinical Oncology · 154
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
2018 · Markus Mayrhofer, Bram De Laere, et al. · Genome Medicine · 142
PDF
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
2020 · Albiruni RA Razak, James M Cleary, et al. · Journal for ImmunoTherapy of Cancer · 133
PDF
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
2018 · Christian Rolfo, Paolo Manca, et al. · ESMO Open · 103
PDF
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
2019 · Daniel P Petrylak, Ronald de Wit, et al. · The Lancet Oncology · 93
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
2013 · D J E Peeters, P-J van Dam, et al. · British Journal of Cancer · 76
PDF
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis
2020 · Evandro de Azambuja, Mariana Brandão, et al. · ESMO Open · 72
PDF
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
2024 · Erika Hamilton, Matthew D. Galsky, et al. · Clinical Cancer Research · 71
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
2022 · Tae Won Kim, Howard A. Burris, et al. · Clinical Cancer Research · 71
PDF
Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis
2013 · I. Pastushenko, P.B. Vermeulen, et al. · British Journal of Dermatology · 60
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
2014 · D. Schadendorf, M.M. Amonkar, et al. · Annals of Oncology · 58
PDF
Abstract PD3-07: Trastuzumab deruxtecan (T-DXd; DS-8201) with nivolumab in patients with HER2-expressing, advanced breast cancer: A 2-part, phase 1b, multicenter, open-label study
2021 · Erika Hamilton, Charles L Shapiro, et al. · Cancer Research · 56
Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid Tumors
2015 · Christian Rolfo, Helen Swaisland, et al. · Advances in Therapy · 45
162O Primary analysis from DS8201-A-U105: A 2-part, open label, phase Ib trial assessing trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing advanced breast cancer
2022 · E.P. Hamilton, C.L. Shapiro, et al. · Annals of Oncology · 36
A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
2019 · ANA Maria Arance Fernandez, Jean-Francois Baurain, et al. · Journal of Clinical Oncology · 36
Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer
2014 · Dieter J.E. Peeters, Anja Brouwer, et al. · Cancer Letters · 35
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer
2025 · Pieter-Jan Volders, Philippe Aftimos, et al. · npj Precision Oncology · 29
Circulating tumor cells and survival in abiraterone‐ and enzalutamide‐treated patients with castration‐resistant prostate cancer
2018 · Bram De Laere, Steffi Oeyen, et al. · The Prostate · 27
PDF
Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications
2014 · I. Pastushenko, P.B. Vermeulen, et al. · British Journal of Dermatology · 19
Works count: 93
Citation count: 3,352
H-index: 24
I10-index: 31
Year
Topic
Type